GlycoMimetics Files 8-K Report
Ticker: CBIO · Form: 8-K · Filed: May 30, 2025 · CIK: 1253689
| Field | Detail |
|---|---|
| Company | Glycomimetics INC (CBIO) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
Related Tickers: GMLX
TL;DR
GMLX filed an 8-K, likely routine. No major news yet.
AI Summary
On May 30, 2025, GlycoMimetics, Inc. filed an 8-K report. The filing indicates an 'Other Event' and is related to the company's ongoing operations and reporting obligations under the Securities Exchange Act of 1934. No specific transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing serves as a public notification of an event or transaction that may be material to investors, fulfilling regulatory requirements for timely disclosure.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for 'Other Events' without specific details of a material event, suggesting it's likely procedural.
Key Players & Entities
- GlycoMimetics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- May 30, 2025 (date) — Date of Report
FAQ
What specific 'Other Event' is GlycoMimetics, Inc. reporting on May 30, 2025?
The provided excerpt does not specify the nature of the 'Other Event' being reported in the 8-K filing.
Is this 8-K filing related to a material event or transaction?
The filing is categorized under 'Other Events,' and the excerpt does not detail any specific material event or transaction.
What is the purpose of a Form 8-K filing?
A Form 8-K filing is used by public companies to announce major corporate events that shareholders should know about in a timely manner.
What is GlycoMimetics, Inc.'s principal executive office address?
GlycoMimetics, Inc.'s principal executive offices are located at P.O. Box 65, Monrovia, Maryland, 21770.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding GLYCOMIMETICS INC (CBIO).